vs

Side-by-side financial comparison of Brookfield Infrastructure Corp (BIPC) and MAXIMUS, INC. (MMS). Click either name above to swap in a different company.

MAXIMUS, INC. is the larger business by last-quarter revenue ($1.3B vs $866.0M, roughly 1.6× Brookfield Infrastructure Corp). MAXIMUS, INC. runs the higher net margin — 7.0% vs -35.7%, a 42.7% gap on every dollar of revenue. On growth, MAXIMUS, INC. posted the faster year-over-year revenue change (-4.1% vs -4.6%).

Brookfield Infrastructure Partners L.P. is a publicly traded limited partnership with corporate headquarters in Toronto, Canada, that engages in the acquisition and management of infrastructure assets on a global basis.

Maximus Inc. is an American government services company, with operations in countries including the United States, Canada, and the United Kingdom. Maximus provides administration and other services for Medicaid, Medicare, health care reform, welfare-to-work, and student loan servicing, among other government programs. The company is based in Tysons, Virginia, has 39,600 employees and a reported annual revenue of $5.3 billion in fiscal year 2024.

BIPC vs MMS — Head-to-Head

Bigger by revenue
MMS
MMS
1.6× larger
MMS
$1.3B
$866.0M
BIPC
Growing faster (revenue YoY)
MMS
MMS
+0.5% gap
MMS
-4.1%
-4.6%
BIPC
Higher net margin
MMS
MMS
42.7% more per $
MMS
7.0%
-35.7%
BIPC

Income Statement — Q2 FY2025 vs Q1 FY2026

Metric
BIPC
BIPC
MMS
MMS
Revenue
$866.0M
$1.3B
Net Profit
$-309.0M
$93.9M
Gross Margin
65.0%
23.7%
Operating Margin
62.7%
10.9%
Net Margin
-35.7%
7.0%
Revenue YoY
-4.6%
-4.1%
Net Profit YoY
-148.1%
128.0%
EPS (diluted)
$1.70

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIPC
BIPC
MMS
MMS
Q4 25
$1.3B
Q3 25
$1.3B
Q2 25
$866.0M
$1.3B
Q1 25
$1.4B
Q4 24
$1.4B
Q3 24
$1.3B
Q2 24
$908.0M
$1.3B
Q1 24
$1.3B
Net Profit
BIPC
BIPC
MMS
MMS
Q4 25
$93.9M
Q3 25
$75.3M
Q2 25
$-309.0M
$106.0M
Q1 25
$96.6M
Q4 24
$41.2M
Q3 24
$72.5M
Q2 24
$643.0M
$89.8M
Q1 24
$80.5M
Gross Margin
BIPC
BIPC
MMS
MMS
Q4 25
23.7%
Q3 25
25.3%
Q2 25
65.0%
26.7%
Q1 25
24.9%
Q4 24
21.5%
Q3 24
22.9%
Q2 24
63.8%
25.3%
Q1 24
23.6%
Operating Margin
BIPC
BIPC
MMS
MMS
Q4 25
10.9%
Q3 25
9.3%
Q2 25
62.7%
12.3%
Q1 25
11.2%
Q4 24
6.2%
Q3 24
8.5%
Q2 24
61.9%
10.8%
Q1 24
9.5%
Net Margin
BIPC
BIPC
MMS
MMS
Q4 25
7.0%
Q3 25
5.7%
Q2 25
-35.7%
7.9%
Q1 25
7.1%
Q4 24
2.9%
Q3 24
5.5%
Q2 24
70.8%
6.8%
Q1 24
6.0%
EPS (diluted)
BIPC
BIPC
MMS
MMS
Q4 25
$1.70
Q3 25
$1.27
Q2 25
$1.86
Q1 25
$1.69
Q4 24
$0.69
Q3 24
$1.18
Q2 24
$1.46
Q1 24
$1.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIPC
BIPC
MMS
MMS
Cash + ST InvestmentsLiquidity on hand
$1.2B
$137.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.2B
$1.7B
Total Assets
$23.9B
$4.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIPC
BIPC
MMS
MMS
Q4 25
$137.6M
Q3 25
$222.4M
Q2 25
$1.2B
$59.8M
Q1 25
$108.1M
Q4 24
$72.7M
Q3 24
$183.1M
Q2 24
$466.0M
$102.8M
Q1 24
$77.4M
Stockholders' Equity
BIPC
BIPC
MMS
MMS
Q4 25
$1.7B
Q3 25
$1.7B
Q2 25
$2.2B
$1.8B
Q1 25
$1.7B
Q4 24
$1.6B
Q3 24
$1.8B
Q2 24
$3.5B
$1.8B
Q1 24
$1.8B
Total Assets
BIPC
BIPC
MMS
MMS
Q4 25
$4.2B
Q3 25
$4.1B
Q2 25
$23.9B
$4.5B
Q1 25
$4.2B
Q4 24
$4.1B
Q3 24
$4.1B
Q2 24
$23.7B
$4.0B
Q1 24
$4.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIPC
BIPC
MMS
MMS
Operating Cash FlowLast quarter
$478.0M
$-244.4M
Free Cash FlowOCF − Capex
$-250.7M
FCF MarginFCF / Revenue
-18.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
-2.60×
TTM Free Cash FlowTrailing 4 quarters
$218.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIPC
BIPC
MMS
MMS
Q4 25
$-244.4M
Q3 25
$649.4M
Q2 25
$478.0M
$-182.7M
Q1 25
$42.7M
Q4 24
$-80.0M
Q3 24
$163.8M
Q2 24
$511.0M
$199.3M
Q1 24
$130.5M
Free Cash Flow
BIPC
BIPC
MMS
MMS
Q4 25
$-250.7M
Q3 25
$641.8M
Q2 25
$-198.2M
Q1 25
$25.5M
Q4 24
$-103.0M
Q3 24
$131.9M
Q2 24
$164.6M
Q1 24
$105.2M
FCF Margin
BIPC
BIPC
MMS
MMS
Q4 25
-18.6%
Q3 25
48.7%
Q2 25
-14.7%
Q1 25
1.9%
Q4 24
-7.3%
Q3 24
10.0%
Q2 24
12.5%
Q1 24
7.8%
Capex Intensity
BIPC
BIPC
MMS
MMS
Q4 25
0.5%
Q3 25
0.6%
Q2 25
1.1%
Q1 25
1.3%
Q4 24
1.6%
Q3 24
2.4%
Q2 24
2.6%
Q1 24
1.9%
Cash Conversion
BIPC
BIPC
MMS
MMS
Q4 25
-2.60×
Q3 25
8.63×
Q2 25
-1.72×
Q1 25
0.44×
Q4 24
-1.94×
Q3 24
2.26×
Q2 24
0.79×
2.22×
Q1 24
1.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIPC
BIPC

Segment breakdown not available.

MMS
MMS

Clinical Services$523.7M39%
Cost Plus Contracts$386.4M29%
Outside The United States$143.2M11%
International Government Agencies$141.0M10%
Technology Solutions$74.8M6%
Employment And Other$70.2M5%
Other Including Local Municipalities And Commercial Customers$17.6M1%

Related Comparisons